(Q38106992)

English

Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target

scientific article published on 16 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target (English)

1 reference

Europe PubMed Central

29 August 2017

1 reference

based on heuristic

inferred from title

object named as

Nick Devoogdt

2

0 references

Serge Muyldermans

object named as

Serge Muyldermans

4

0 references

author name string

Jens De Vos

1

1 reference

Europe PubMed Central

29 August 2017

Tony Lahoutte

3

1 reference

Europe PubMed Central

29 August 2017

language of work or name

0 references

publication date

16 May 2013

1 reference

Europe PubMed Central

29 August 2017

Expert Opinion on Biological Therapy

1 reference

Europe PubMed Central

29 August 2017

13

1 reference

Europe PubMed Central

29 August 2017

8

1 reference

Europe PubMed Central

29 August 2017

1149-1160

1 reference

Europe PubMed Central

29 August 2017

Molecular imaging in drug development

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Peptide-based probes for targeted molecular imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Protein-based tumor molecular imaging probes

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

The future of molecular imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Molecular imaging: 18F-FDG PET and a whole lot more.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Imaging of the unstable plaque: how far have we got?

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

A review of molecular imaging studies reaching the clinical stage

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Use of (64)Cu-labeled fibronectin domain with EGFR-overexpressing tumor xenograft: molecular imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Naturally occurring antibodies devoid of light chains

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Camelid immunoglobulins and nanobody technology.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Immuno-imaging using nanobodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Molecular imaging using Nanobodies: a case study.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Engineered antibody fragments and the rise of single domains

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Efficient tumor targeting by single-domain antibody fragments of camels

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Selection and characterization of HER2/neu-binding affibody ligands

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Structure of a nanobody-stabilized active state of the β(2) adrenoceptor

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Single-domain antibody fragments with high conformational stability

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Shedding light onto live molecular targets

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

In vivo detection of amyloid-β deposits using heavy chain antibody fragments in a transgenic mouse model for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Kinetic analysis of novel mono- and multivalent VHH-fragments and their application for molecular imaging of brain tumours.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobodies as tools for in vivo imaging of specific immune cell types

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Differential tumor-targeting abilities of three single-domain antibody formats

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Nanobody-coupled microbubbles as novel molecular tracer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Drug transport across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Site-Specific Labeling of His-Tagged Nanobodies with 99mTc: A Practical Guide

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.800478

21 January 2018

Identifiers

10.1517/14712598.2013.800478

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38106992&oldid=1741896345"